List of Tables
Table 1. Global Catheter-Associated Bloodstream Infection Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Catheter-Associated Bloodstream Infection Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Catheter-Associated Bloodstream Infection Treatment Market Competitive Situation by Manufacturers in 2023
Table 4. Global Catheter-Associated Bloodstream Infection Treatment Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Catheter-Associated Bloodstream Infection Treatment Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Catheter-Associated Bloodstream Infection Treatment Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Catheter-Associated Bloodstream Infection Treatment Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Catheter-Associated Bloodstream Infection Treatment Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Catheter-Associated Bloodstream Infection Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Catheter-Associated Bloodstream Infection Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Catheter-Associated Bloodstream Infection Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Catheter-Associated Bloodstream Infection Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Catheter-Associated Bloodstream Infection Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Catheter-Associated Bloodstream Infection Treatment as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Catheter-Associated Bloodstream Infection Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Catheter-Associated Bloodstream Infection Treatment Sales by Region (2019-2024) & (K Units)
Table 18. Global Catheter-Associated Bloodstream Infection Treatment Sales Market Share by Region (2019-2024)
Table 19. Global Catheter-Associated Bloodstream Infection Treatment Sales by Region (2025-2030) & (K Units)
Table 20. Global Catheter-Associated Bloodstream Infection Treatment Sales Market Share by Region (2025-2030)
Table 21. Global Catheter-Associated Bloodstream Infection Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Catheter-Associated Bloodstream Infection Treatment Revenue Market Share by Region (2019-2024)
Table 23. Global Catheter-Associated Bloodstream Infection Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Catheter-Associated Bloodstream Infection Treatment Revenue Market Share by Region (2025-2030)
Table 25. North America Catheter-Associated Bloodstream Infection Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Catheter-Associated Bloodstream Infection Treatment Sales by Country (2019-2024) & (K Units)
Table 27. North America Catheter-Associated Bloodstream Infection Treatment Sales by Country (2025-2030) & (K Units)
Table 28. North America Catheter-Associated Bloodstream Infection Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Catheter-Associated Bloodstream Infection Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Catheter-Associated Bloodstream Infection Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Catheter-Associated Bloodstream Infection Treatment Sales by Country (2019-2024) & (K Units)
Table 32. Europe Catheter-Associated Bloodstream Infection Treatment Sales by Country (2025-2030) & (K Units)
Table 33. Europe Catheter-Associated Bloodstream Infection Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Catheter-Associated Bloodstream Infection Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Catheter-Associated Bloodstream Infection Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Catheter-Associated Bloodstream Infection Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Catheter-Associated Bloodstream Infection Treatment Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Catheter-Associated Bloodstream Infection Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Catheter-Associated Bloodstream Infection Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Catheter-Associated Bloodstream Infection Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Catheter-Associated Bloodstream Infection Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Catheter-Associated Bloodstream Infection Treatment Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Catheter-Associated Bloodstream Infection Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Catheter-Associated Bloodstream Infection Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Catheter-Associated Bloodstream Infection Treatment Sales (K Units) by Type (2019-2024)
Table 51. Global Catheter-Associated Bloodstream Infection Treatment Sales (K Units) by Type (2025-2030)
Table 52. Global Catheter-Associated Bloodstream Infection Treatment Sales Market Share by Type (2019-2024)
Table 53. Global Catheter-Associated Bloodstream Infection Treatment Sales Market Share by Type (2025-2030)
Table 54. Global Catheter-Associated Bloodstream Infection Treatment Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Catheter-Associated Bloodstream Infection Treatment Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Catheter-Associated Bloodstream Infection Treatment Revenue Market Share by Type (2019-2024)
Table 57. Global Catheter-Associated Bloodstream Infection Treatment Revenue Market Share by Type (2025-2030)
Table 58. Global Catheter-Associated Bloodstream Infection Treatment Price (US$/Unit) by Type (2019-2024)
Table 59. Global Catheter-Associated Bloodstream Infection Treatment Price (US$/Unit) by Type (2025-2030)
Table 60. Global Catheter-Associated Bloodstream Infection Treatment Sales (K Units) by Application (2019-2024)
Table 61. Global Catheter-Associated Bloodstream Infection Treatment Sales (K Units) by Application (2025-2030)
Table 62. Global Catheter-Associated Bloodstream Infection Treatment Sales Market Share by Application (2019-2024)
Table 63. Global Catheter-Associated Bloodstream Infection Treatment Sales Market Share by Application (2025-2030)
Table 64. Global Catheter-Associated Bloodstream Infection Treatment Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Catheter-Associated Bloodstream Infection Treatment Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Catheter-Associated Bloodstream Infection Treatment Revenue Market Share by Application (2019-2024)
Table 67. Global Catheter-Associated Bloodstream Infection Treatment Revenue Market Share by Application (2025-2030)
Table 68. Global Catheter-Associated Bloodstream Infection Treatment Price (US$/Unit) by Application (2019-2024)
Table 69. Global Catheter-Associated Bloodstream Infection Treatment Price (US$/Unit) by Application (2025-2030)
Table 70. AstraZeneca Corporation Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. AstraZeneca Catheter-Associated Bloodstream Infection Treatment Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. CorMedix, Inc. Corporation Information
Table 76. CorMedix, Inc. Description and Business Overview
Table 77. CorMedix, Inc. Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. CorMedix, Inc. Catheter-Associated Bloodstream Infection Treatment Product
Table 79. CorMedix, Inc. Recent Developments/Updates
Table 80. Citus Pharmaceuticals Corporation Information
Table 81. Citus Pharmaceuticals Description and Business Overview
Table 82. Citus Pharmaceuticals Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Citus Pharmaceuticals Catheter-Associated Bloodstream Infection Treatment Product
Table 84. Citus Pharmaceuticals Recent Developments/Updates
Table 85. Fresenius Medical Care Corporation Information
Table 86. Fresenius Medical Care Description and Business Overview
Table 87. Fresenius Medical Care Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Fresenius Medical Care Catheter-Associated Bloodstream Infection Treatment Product
Table 89. Fresenius Medical Care Recent Developments/Updates
Table 90. Glenmark Pharmaceuticals Ltd. Corporation Information
Table 91. Glenmark Pharmaceuticals Ltd. Description and Business Overview
Table 92. Glenmark Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Glenmark Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Product
Table 94. Glenmark Pharmaceuticals Ltd. Recent Developments/Updates
Table 95. Geistlich Pharma Corporation Information
Table 96. Geistlich Pharma Description and Business Overview
Table 97. Geistlich Pharma Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Geistlich Pharma Catheter-Associated Bloodstream Infection Treatment Product
Table 99. Geistlich Pharma Recent Developments/Updates
Table 100. Merck & Co., Inc. Corporation Information
Table 101. Merck & Co., Inc. Description and Business Overview
Table 102. Merck & Co., Inc. Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Merck & Co., Inc. Catheter-Associated Bloodstream Infection Treatment Product
Table 104. Merck & Co., Inc. Recent Developments/Updates
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Pfizer Catheter-Associated Bloodstream Infection Treatment Product
Table 109. Pfizer Recent Developments/Updates
Table 110. TauroPhar GmbH Corporation Information
Table 111. TauroPhar GmbH Description and Business Overview
Table 112. TauroPhar GmbH Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. TauroPhar GmbH Catheter-Associated Bloodstream Infection Treatment Product
Table 114. TauroPhar GmbH Recent Developments/Updates
Table 115. Xellia Pharmaceuticals Ltd. Corporation Information
Table 116. Xellia Pharmaceuticals Ltd. Description and Business Overview
Table 117. Xellia Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Xellia Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Product
Table 119. Xellia Pharmaceuticals Ltd. Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Catheter-Associated Bloodstream Infection Treatment Distributors List
Table 123. Catheter-Associated Bloodstream Infection Treatment Customers List
Table 124. Catheter-Associated Bloodstream Infection Treatment Market Trends
Table 125. Catheter-Associated Bloodstream Infection Treatment Market Drivers
Table 126. Catheter-Associated Bloodstream Infection Treatment Market Challenges
Table 127. Catheter-Associated Bloodstream Infection Treatment Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Catheter-Associated Bloodstream Infection Treatment
Figure 2. Global Catheter-Associated Bloodstream Infection Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Catheter-Associated Bloodstream Infection Treatment Market Share by Type in 2023 & 2030
Figure 4. Antibacterial Agents Product Picture
Figure 5. Antibiotic Product Picture
Figure 6. Global Catheter-Associated Bloodstream Infection Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Catheter-Associated Bloodstream Infection Treatment Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Specialist Clinic
Figure 10. Other
Figure 11. Global Catheter-Associated Bloodstream Infection Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Catheter-Associated Bloodstream Infection Treatment Market Size (2019-2030) & (US$ Million)
Figure 13. Global Catheter-Associated Bloodstream Infection Treatment Sales (2019-2030) & (K Units)
Figure 14. Global Catheter-Associated Bloodstream Infection Treatment Average Price (US$/Unit) & (2019-2030)
Figure 15. Catheter-Associated Bloodstream Infection Treatment Report Years Considered
Figure 16. Catheter-Associated Bloodstream Infection Treatment Sales Share by Manufacturers in 2023
Figure 17. Global Catheter-Associated Bloodstream Infection Treatment Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Catheter-Associated Bloodstream Infection Treatment Players: Market Share by Revenue in 2023
Figure 19. Catheter-Associated Bloodstream Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Catheter-Associated Bloodstream Infection Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Catheter-Associated Bloodstream Infection Treatment Sales Market Share by Country (2019-2030)
Figure 22. North America Catheter-Associated Bloodstream Infection Treatment Revenue Market Share by Country (2019-2030)
Figure 23. United States Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Catheter-Associated Bloodstream Infection Treatment Sales Market Share by Country (2019-2030)
Figure 26. Europe Catheter-Associated Bloodstream Infection Treatment Revenue Market Share by Country (2019-2030)
Figure 27. Germany Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Catheter-Associated Bloodstream Infection Treatment Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Catheter-Associated Bloodstream Infection Treatment Revenue Market Share by Region (2019-2030)
Figure 34. China Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Catheter-Associated Bloodstream Infection Treatment Sales Market Share by Country (2019-2030)
Figure 42. Latin America Catheter-Associated Bloodstream Infection Treatment Revenue Market Share by Country (2019-2030)
Figure 43. Mexico Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales Market Share by Country (2019-2030)
Figure 47. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Catheter-Associated Bloodstream Infection Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Catheter-Associated Bloodstream Infection Treatment by Type (2019-2030)
Figure 52. Global Revenue Market Share of Catheter-Associated Bloodstream Infection Treatment by Type (2019-2030)
Figure 53. Global Catheter-Associated Bloodstream Infection Treatment Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Catheter-Associated Bloodstream Infection Treatment by Application (2019-2030)
Figure 55. Global Revenue Market Share of Catheter-Associated Bloodstream Infection Treatment by Application (2019-2030)
Figure 56. Global Catheter-Associated Bloodstream Infection Treatment Price (US$/Unit) by Application (2019-2030)
Figure 57. Catheter-Associated Bloodstream Infection Treatment Value Chain
Figure 58. Catheter-Associated Bloodstream Infection Treatment Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed